Page last updated: 2024-09-03

nifekalant hydrochloride and Ventricular Dysfunction

nifekalant hydrochloride has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daikoku, S; Kamakura, S; Kurita, T; Miyazaki, S; Morii, I; Nonogi, H; Sutani, Y; Takenaka, K; Yasuda, S	1

Other Studies

1 other study(ies) available for nifekalant hydrochloride and Ventricular Dysfunction

Article	Year
Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction. Japanese circulation journal, 2001, Volume: 65, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Tachycardia; Ventricular Dysfunction	2001

Article

Year

Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction.

Japanese circulation journal, 2001, Volume: 65, Issue:1

Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Tachycardia; Ventricular Dysfunction

2001